Systemic and cavernosal plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction

Citation
Aj. Becker et al., Systemic and cavernosal plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction, WORLD J URO, 19(5), 2001, pp. 371-376
Citations number
30
Categorie Soggetti
Urology & Nephrology
Journal title
WORLD JOURNAL OF UROLOGY
ISSN journal
07244983 → ACNP
Volume
19
Issue
5
Year of publication
2001
Pages
371 - 376
Database
ISI
SICI code
0724-4983(200111)19:5<371:SACPLO>2.0.ZU;2-Q
Abstract
The role of the sympathetic adrenergic nerves in mediating the constant ton e of penile flaccidity and returning the erect penis to its flaccid state i s fairly well established. However, it is not yet known whether additional nonadrenergic transmitters are involved in this process. The peptide endoth elin-1 (ET-1) may be one of the factors contributing to such a control. Mor eover, it has been speculated that ET-1 might be involved in the pathophysi ology of penile erection. The present study was undertaken to determine whe ther or not there is a difference in the courses of ET-1/-2 plasma levels r ecorded in systemic and cavernosal blood taken from healthy males and patie nts with erectile dysfunction (ED) during different penile conditions (flac cidity, tumescence/rigidity, detumescence). The study groups comprised 33 h ealthy adult males and 25 patients. The subjects were exposed to visual and tactile erotic stimuli in order to elicit penile tumescence and, in the gr oup of healthy volunteers, rigidity. Whole blood was aspirated from the cor pus cavernosum and the cubital vein, and ET-1/-2 was determined in plasma a liquots by means of an enzyme-linked immunosorbent assay (ELISA). Mean syst emic and cavernosal plasma levels of ET-1/-2 in blood samples obtained from the volunteers was 0.2-0.7 fmol/ml. In the healthy males, no changes in ET -1/-2 levels were observed in the systemic and cavernosal blood during peni le tumescence, rigidity and detumescence. In the patients, mean plasma ET-1 /-2 levels during penile flaccidity and detumescence were found to be highe r in the systemic circulation than in the cavernosal blood (flaccidity 0.52 +/- 0.38 fmol/ml vs 0.48 +/- 0.46 fmol/ml, respectively; detumescence 0.53 +/- 0.33 fmol/ml vs 0.27 +/- 0.11 fmol/ml, respectively). No differences i n the plasma courses of ET-1/-2 were found between patients with an organog enic and those with a psychogenic aetiology of ED. During detumescence, the mean ET-1/-2 level was lower in the cavernosal blood taken from the patien ts than in the samples obtained from the healthy males. Our study revealed a difference in the profiles of ET-1/-2 in the cavernosal blood of healthy subjects and patients with erectile dysfunction. Nevertheless, since this d ifference seemed to be of no physiological significance, our findings contr adict the hypothesis of the ultimate importance of ET-1 in the control of p enile flaccidity and detumescence and do not support speculations regarding the involvement of ET-1 in the pathophysiology of erectile dysfunction.